Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome — mHealth  

HIV Clinical Trial

Official title: Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome

Status Recruiting

Clinical Trial Summary

The investigators propose to adopt sustainable community networks (in this case churches) to implement an integrated community-based screening that incorporates mobile health technology (mHealth) to make prenatal test results available at the point-of-delivery to guide medical management.

Clinical Trial Description

The investigators will develop and test the feasibility, acceptability, and usability of a mobile health platform that captures results for HIV, Hepatitis B virus (HBV) and sickle cell genotype obtained from participants during the Healthy Beginning Initiative (HBI) program; store data in a secure, web-based database; encrypt data on a "smart card" which is given to participants, and make these data available at the point-of-delivery using a cell-phone application to read the "smart card". Data on the web-based database can also be accessed directly using the cell phone application. Evidence exists that when clinician have maternal records available at the point of delivery, they are more likely to initiate antiretroviral prophylaxis for HIV-exposed infants, administer the first dose of hepatitis B vaccine with 24 hours for infants born to women who have positive hepatitis B surface antigen and screen infants born to mothers with sickle cell trait to allow early identification and initiation of penicillin prophylaxis for infants who have sickle cell disease. ;

Related Conditions & MeSH terms

• Anemia, Sickle Cell
• Hepatitis B
• HIV
• Sickle Cell Disease

• NCT number: NCT03027258
• Study type: Interventional
• Source: University of Nevada, Las Vegas
• Contact: Echezona Ezeanolue, MD, MPH
• Phone: 7028952687
• Email: echezona.ezeanolue@unlv.edu
• Status: Recruiting
• Phase: N/A
• Start date: September 2016
• Completion date: January 2018